Interim clinical commissioning policy: Treatments for non-hospitalised patients with COVID-19

Document first published:
Page updated:
Publication type:

The following treatments are recommended to be available for non-hospitalised adults and children with COVID-19 treated in accordance with the criteria set out in this document. This policy applies to non-hospitalised patients with COVID-19 who are symptomatic and showing no evidence of clinical recovery and covers the following treatment options:

  • First-line: nirmatrelvir plus ritonavir (antiviral)
  • Second-line: remdesivir (antiviral)
  • Third-line: molnupiravir (antiviral)